Retatrutide is a novel triple agonist of the GLP-1/GIP/GCGR Glucose-dependent Insulinotropic Polypeptide, Glucagon-Like Peptide-1 and glucagon receptors GCGR. A 48-week phase 2 obesity study demonstrated weight reductions of 22.8% and 24.2% with retatrutide 8 and 12 mg, respectively. Considered one of the most advanced weight loss compounds ever created. If you have been using Semaglutide and have seemingly stalled out, Retatrutide will help kickstart your weight loss journey once more.
Every vial comes with everything you'll need for a sucessful program, Dosing program, Syringes, Alcohol swab pads etc...
Retatrutide 15mg (Triple Action Weight Management)
Retatrutide side effects are similar to the side effects of GLP-1 (Semaglutide) and dual agonists (Tirzepatide). These include nausea, vomiting, diarrhea, and acid reflux.
Weeks 1-8 ( 1-4 [1.5mg weekly] 5-8 [2mg weekly] )
Weeks 9-12 ( 3.5mg weekly)
Monthly Maintanence 13+ Weeks (3.75mg weekly)